- Home
- IMMX vs CDRO Comparison
IMMX vs CDRO Comparison
Compare IMMX & CDRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMMX | CDRO |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 306.2M | 319.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | IMMX | CDRO |
|---|---|---|
| Price | $4.88 | $7.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $9.00 |
| AVG Volume (30 Days) | ★ 1.1M | 23.3K |
| Earning Date | 11-07-2025 | 02-28-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $239,490,311.00 |
| Revenue This Year | N/A | $11.31 |
| Revenue Next Year | N/A | $7.99 |
| P/E Ratio | ★ N/A | $296.77 |
| Revenue Growth | N/A | ★ 7.83 |
| 52 Week Low | $1.34 | $5.18 |
| 52 Week High | $7.73 | $8.75 |
Technical Indicators
Market Signals| Indicator | IMMX | CDRO |
|---|---|---|
| Relative Strength Index (RSI) | 43.62 | 51.41 |
| Support Level | $4.85 | $7.57 |
| Resistance Level | $5.25 | $8.12 |
| Average True Range (ATR) | 0.37 | 0.30 |
| MACD | -0.16 | -0.08 |
| Stochastic Oscillator | 10.70 | 13.04 |
Price Performance
Historical ComparisonAbout IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Mexico, Colombia, and Other countries. where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. The company derives maximum revenue from Mexico.